Question Bank › Conversion calendar in hand

Conversion calendar in hand

Conversion calendar in hand: management narrates the coming year as dated deliveries of business already secured

Calls Tested
443
Answered YES
6
Hit Rate
1.4%
rare by design

ProPhase Labs, Inc. (PRPH) — this company's answers

NO on the Q1 2023 call 2023-05-11 F
The model's full reasoning — Q1 2023 call → NO我们根据提供的电话会议记录,判断管理层是否给出了一个具体的时间表,其中包含已经确定或正在进行的业务,并附有大致的时间框架,从而将未来的叙述呈现为一系列启动事项,而非对需求的希望。 首先,检查管理层是否提到了已经确定的、具体的业务项目,并附有时间框架。 在记录中,管理层讨论了多个业务领域: - 制造设施:提到“我们的制造设施已满负荷运转,需求巨大”,并提到“我们预计明年(2024年)至少有2500万美元的收入需求”,但这是基于需求,而非已签约的订单。管理层说“我们受到产能建设速度的限制”,但未提及已签署的合同或已确定的订单。这更多是需求驱动,而非已确定的业务。 - Nebula Genomics:管理层提到“我们正在等待验证,这将再需要几个月,然后我们将在今年下半年开始建立我们的全基因组测序业务”,并说“我们预计在今年下半年,特别是第四季度,建立一个非常好的Nebula Genomics业务”。但这是基于验证完成后的预期,验证尚未完成,因此属于待定事项。此外,管理层提到“我们目前只直接面向消费者销售”,并提到“我们正在寻找机会在零售店上架”,但这些都是机会,而非已确定的。 - 食管癌检测:管理层提到“我们相信我们将在明年年初获得CPT代码并商业化我们的检测”,但这是明年的事,且依赖于监管批准,属于待定。 - Linebacker:管理层提到“我们正在继续获得令人兴奋的结果”,但未提及具体时间表。 - 临床实验室:管理层提到“我们正在等待验证完成,这需要几个月”,然后“我们将在今年下半年开始建立这些业务”,但验证尚未完成。 管理层还提到“我们正在等待验证,这将再需要几个月”,并说“我们预计在今年下半年,特别是第四季度,建立一个非常好的Nebula Genomics业务”。但这些都是基于验证完成后的预期,验证尚未完成,因此属于待定事项。 此外,管理层明确表示“今年不会是盈利的一年”,并说“我们专注于建立公司的潜在价值”,而不是盈利。管理层没有给出一个具体的时间表,列出已确定的业务及其启动时间。相反,他们谈论的是机会、需求、验证和未来计划。 关于制造设施,管理层提到“我们预计明年(2024年)至少有2500万美元的收入需求”,但这是基于需求,而非已签约的订单。管理层说“我们受到产能建设速度的限制”,但未提及已签署的合同或已确定的订单。 因此,管理层没有提供已确定业务的具体时间表。他们谈论的是正在进行的验证、未来的商业化计划,以及需求驱动的增长,但这些都是希望和预期,而非已确定的、已签署的或已启动的业务。 此外,管理层提到“我们正在等待验证,这将再需要几个月”,并说“我们预计在今年下半年,特别是第四季度,建立一个非常好的Nebula Genomics业务”。但这些都是基于验证完成后的预期,验证尚未完成,因此属于待定事项。 因此,答案应为NO。

← Back to the full PRPH analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, when management talks about the company's NEXT FOUR OR SO QUARTERS, does it lay out a TIMETABLE OF SPECIFIC CONVERSIONS \u2014 identified pieces of business that are ALREADY SECURED OR ALREADY IN MOTION, each attached to an at-least-approximate time frame in which it starts contributing \u2014 so that the forward story reads as a schedule of things turning on, rather than as hopes about demand?\n\nAnswer YES when management's own words convey BOTH of the following as one coherent forward account, in whatever form fits the business:\n\n(1) THE ITEMS ON THE TIMETABLE ARE ALREADY REAL. Management identifies concrete business whose existence is no longer in question \u2014 already won, signed, awarded, ordered, booked, contracted, built, launched, closed, or already ramping \u2014 in whatever form fits the industry: contracted work or orders scheduled for delivery; a facility, capacity, product, service, or location recently completed or opening on a stated timetable and now filling; customers or programs already signed that go live or scale on a described schedule; an acquisition or expansion already closed whose contribution phases in; committed volumes stepping up on agreed dates. One substantial item or several smaller ones together both count. Items still being pursued, negotiated, piloted without commitment, or awaiting approvals, financing, or customer decisions do NOT count toward the timetable.\n\n(2) MANAGEMENT ATTACHES TIMING AND TREATS THE SCHEDULE AS THE FORWARD STORY. Management gives each identified item an at-least-rough time anchor within roughly the coming year (this quarter, next quarter, by mid-year, second half, a named month or season) and presents working through this sequence \u2014 starting, ramping, delivering, onboarding, filling \u2014 as the main driver of where the company's results go from here, conveying directly or plainly in substance that the period just reported does not yet meaningfully reflect these contributions, so today's numbers describe the company before the scheduled conversions land.\n\nAnswer NO if the forward discussion rests mainly on demand strength, market conditions, pipeline, opportunities being pursued, or general optimism, with no dated schedule of secured items. NO if the timetable consists of routine, ordinary-course activity at the company's usual scale \u2014 the normal cadence of openings, orders, or seasonal work it always has \u2014 that management does not present as stepping the company beyond its current level. NO if the named items are contingent on approvals, financing, negotiations, or decisions not yet made, or if the only timing given is vague ('over time', 'in the coming years', 'eventually'). NO if the scheduled items' contributions are already substantially reflected in the reported results. NO if management is chiefly explaining delays, slippage, cancellations, or problems with a previously described schedule. NO if the schedule is assembled only in an analyst's question or model that management does not itself adopt.\n\nUse only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
ESEA Euroseas Ltd. Q4 2022 2023-02-15 C+
SOL ReneSola Ltd Q3 2022 2022-12-01 C+
FLL Full House Resorts, Inc. Q3 2022 2022-11-07 B
FAT FAT Brands Inc. Q4 2021 2022-03-21 F
CPK Chesapeake Utilities Corporation Q3 2017 2017-11-10 A
ESE ESCO Technologies Inc. Q2 2016 2016-05-03 A

How the model reasoned

CPK · Q3 2017 → YESThe question is about whether management lays out a timetable of specific conversions for the next four or so quarters, with already secured business and approximate time frames.
SOL · Q3 2022 → YESThe question is about whether management lays out a timetable of specific conversions for the next four or so quarters, with already secured items and approximate time frames.
FLL · Q3 2022 → YESThe question is about whether management lays out a timetable of specific conversions for the next four or so quarters, with already secured items and approximate time frames.

More from the question bank

Betting on a customer they cannot yet nameGround-level proof points accumulatingWinning more per swing than they used to — aFresh order-of-magnitude reference changeThis quarter could not have been described lOutside actors already movingAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.